Inventor

Daniel F. Veber

Inventor

Ambler, PA, US

Overview

1976–2009

Patent span

Chemistry

Primary field (CPC C)

Patents· 79 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary

C07KPeptides23%

A61KPreparations for medical, dental or toiletry purposes19%

C07DHeterocyclic compounds14%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests13%

C07CAcyclic or carbocyclic compounds6%

Y02ATechnologies for adaptation to climate change4%

C12NMicroorganisms or enzymes2%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%

G01NInvestigating or analysing materials by determining their chemical or physical properties1%

PatentTitleYear

7,563,784'Protease inhibitors'2009 7,405,209'Protease inhibitors'2008 7,304,082'1,2,4-triazole derivatives, compositions, process of making and methods of use'2007 7,071,184'Protease inhibitors'2006 6,596,715'Protease inhibitors'2003 6,583,137'Protease inhibitors'2003 6,566,373'Protease inhibitors'2003 6,534,498'Protease inhibitors'2003 6,518,267'Protease inhibitors'2003 6,369,077'Protease inhibitors'2002 6,331,542'Protease inhibitors'2001 6,262,113'IL-8 receptor antagonists'2001 6,232,342'Protease inhibitors'2001 6,211,373'Phenyl urea antagonists of the IL-8 receptor'2001 6,180,675'IL-8 receptor antagonists'2001 6,005,008'IL-8 receptor antagonists'1999 5,998,470'Protease inhibitors'1999 5,886,044'IL-8 receptor antagonists'1999 5,780,483'IL-8 receptor antagonists'1998 5,693,643'Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists'1997 5,681,926'Thrombin receptor binding peptides'1997 5,672,582'Thrombin inhibitors'1997 5,648,352'Piperazinylcamphorsulfonyl oxytocin antagonists'1997 5,492,917'Endothelin antagonists incorporating a cyclobutane'1996 5,457,177'Thrombin receptor radioligands'1995 5,420,133'Quinazolinones substituted with phenoxyphenylacetic acid derivatives'1995 5,374,638'Six membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives used to treat asthma'1994 5,374,622'Fibrinogen receptor antagonists'1994 5,340,798'Fibrinogen receptor antagonists'1994 5,338,723'Fibrinogen receptor antagonists'1994 5,225,528'Cyclic hexapeptide oxytocin antagonists'1993 5,204,328'Peptides having atrial natriuretic factor activity'1993 5,091,366'Peptides having ANF activity'1992 5,061,693'Fibrinogen receptor antagonists'1991 5,057,603'Peptides having ANF activity'1991 5,023,233'Fibrinogen receptor antagonists'1991 5,006,511'Di- or tripeptide renin inhibitors containing lactam conformational restriction in achpa'1991 4,782,043'Renin inhibitors containing a C-terminal amide cycle'1988 4,748,153'Compounds having somatostatin-like activity useful as local anti-inflammatory agents'1988 4,680,283'Analogs of substance P and eledoisin'1987 4,668,770'Renin inhibitory tripeptides'1987 4,663,310'Renin inhibitors containing 2-substituted statine'1987 4,659,691'Novel cyclic Hexapeptide LHRH antagonists'1987 4,656,188'Ace inhibitors in macular degeneration'1987 4,628,084'Process for 3-acylamino benzodiazepines'1986 4,493,934'2(3-Amino-2-oxopyrrolidin-1-yl) acetic acid and n-acylated derivatives thereof'1985 4,485,099'Renin inhibitors containing a C-terminal amide cycle'1984 4,479,941'Renin inhibitory peptides having PHE.sup.13 delection'1984 4,478,826'Renin inhibitory peptides'1984 4,477,441'Renin inhibitors containing a C-terminal disulfide cycle'1984 4,477,440'Renin inhibitors containing an n-terminal disulfide cycle'1984 4,470,971'Renin inhibitory peptides having His.sup.13'1984 4,439,359'Cyclic octapeptide analogs of neurotensin'1984 4,384,994'Renin inhibitory peptides'1983 4,377,515'Long lasting agonists and antagonists of LH-RH'1983 4,360,516'Modified D-retro cyclic hexapeptide somatostatin analogs'1982 4,310,518'Cyclic hexapeptide somatostatin analogs'1982 4,301,151'Long-lasting agonists of enkephalin'1981 4,254,107'Long-lasting agonists of enkephalin'1981 4,235,886'Cyclic hexapeptide somatostatin analogs'1980 4,192,875'Cyclic hexapeptide'1980 4,191,754'Bicyclic somatostatin analogs'1980 4,190,648'Peptides having somatostatin activity'1980 4,162,248'Somatostatin analogs'1979 4,161,521'Somatostatin analogs'1979 4,146,612'Somatostatin analogs'1979 4,140,767'Somatostatin analogs'1979 4,139,526'Somatostatin analogs'1979 4,130,554'Process for preparing somatostatin analog'1978 4,115,554'Somatostatin analogs'1978 4,108,987'Cyclic hexapeptides'1978 4,098,777'Process for the preparation of pyroglutamyl-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn'1978 4,066,749'Tetrapeptide analog of TRH'1978 4,038,282'Pyridyl-4-methyl-succinimidocarbonate and process for its preparation'1977 4,038,306'N-t-butoxycarbonyl-S-lower alkanoylamidomethyl-cysteine and p-nitrophenyl esters'1977 4,006,152'.epsilon.-N-pyridyl-4-methyloxycarbonyllysine'1977 3,959,248'Analogs of thyrotropin-releasing hormone'1976 3,950,348'Process for preparing e-pyridyl-4-methyloxycarbonyllysine'1976 3,948,971'N-protected-.alpha.-amino acid compounds'1976

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1976–1997Patents assigned to MERCK & CO INC (60)· patent assignee history

1976–2009Based in Ambler, PA, US· patent location history

1998–2009Patents assigned to SMITHKLINE BEECHAM CORP (19)· patent assignee history

2003–2008Patents assigned to SMITHKLINE BEECHAM PLC (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
MERCK & CO INC	60	1976–1997
SMITHKLINE BEECHAM CORP	19	1998–2009
SMITHKLINE BEECHAM PLC	2	2003–2008

Locations

Location	Patents	Span
Ambler, Pennsylvania, US	79	1976–2009